| Disparities in telemedicine during COVID‐19 AS Qian, MK Schiaffino, V Nalawade, L Aziz, FV Pacheco, B Nguyen, ... Cancer medicine 11 (4), 1192-1201, 2022 | 77 | 2022 |
| Association between African American race and clinical outcomes in men treated for low-risk prostate cancer with active surveillance R Deka, PT Courtney, JK Parsons, TJ Nelson, V Nalawade, E Luterstein, ... Jama 324 (17), 1747-1754, 2020 | 72 | 2020 |
| Evaluation of the use of cancer registry data for comparative effectiveness research A Kumar, ZD Guss, PT Courtney, V Nalawade, P Sheridan, RR Sarkar, ... JAMA Network Open 3 (7), e2011985-e2011985, 2020 | 69 | 2020 |
| Predicting persistent opioid use, abuse, and toxicity among cancer survivors LK Vitzthum, P Riviere, P Sheridan, V Nalawade, R Deka, T Furnish, ... JNCI: Journal of the National Cancer Institute 112 (7), 720-727, 2020 | 59 | 2020 |
| Risk of pelvic fracture with radiation therapy in older patients LK Vitzthum, H Park, K Zakeri, ES Heide, V Nalawade, AJ Mundt, F Vaida, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 485-492, 2020 | 30 | 2020 |
| Clinical data prediction model to identify patients with early-stage pancreatic cancer Q Chen, DR Cherry, V Nalawade, EM Qiao, A Kumar, AM Lowy, ... JCO clinical cancer informatics 5, 279-287, 2021 | 26 | 2021 |
| The influence of patient–provider language concordance in cancer care: results of the Hispanic outcomes by language approach (HOLA) randomized trial DM Seible, S Kundu, A Azuara, DR Cherry, S Arias, VV Nalawade, J Cruz, ... International Journal of Radiation Oncology* Biology* Physics 111 (4), 856-864, 2021 | 24 | 2021 |
| Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy R Deka, BS Rose, AK Bryant, RR Sarkar, V Nalawade, R McKay, ... Cancer 125 (7), 1070-1080, 2019 | 24 | 2019 |
| Palliative radiotherapy versus esophageal stent placement in the management of patients with metastatic esophageal cancer EJ Martin, AR Bruggeman, VV Nalawade, RR Sarkar, EM Qiao, BS Rose, ... Journal of the National Comprehensive Cancer Network 18 (5), 569-574, 2020 | 22 | 2020 |
| Tobacco smoking and death from prostate cancer in US veterans P Riviere, A Kumar, E Luterstein, LK Vitzthum, V Nalawade, RR Sarkar, ... Prostate Cancer and Prostatic Diseases 23 (2), 252-259, 2020 | 21 | 2020 |
| Claims-based approach to predict cause-specific survival in men with prostate cancer P Riviere, C Tokeshi, J Hou, V Nalawade, R Sarkar, AJ Paravati, ... JCO clinical cancer informatics 3, 1-7, 2019 | 21 | 2019 |
| Disparities in telemedicine utilization for urology patients during the COVID-19 pandemic J Javier-DesLoges, M Meagher, S Soliman, J Yuan, K Hakimi, F Ghali, ... Urology 163, 76-80, 2022 | 19 | 2022 |
| Outcomes for muscle-invasive bladder cancer with radical cystectomy or trimodal therapy in US veterans A Kumar, DR Cherry, PT Courtney, V Nalawade, N Kotha, PJ Riviere, ... European Urology Open Science 30, 1-10, 2021 | 19 | 2021 |
| Racial, ethnic, and socioeconomic discrepancies in opioid prescriptions among older patients with cancer LK Vitzthum, V Nalawade, P Riviere, W Sumner, T Nelson, LK Mell, ... JCO oncology practice 17 (6), e703-e713, 2021 | 19 | 2021 |
| Association of androgen deprivation therapy with dementia in men with prostate cancer who receive definitive radiation therapy R Deka, DR Simpson, AK Bryant, V Nalawade, R McKay, JD Murphy, ... JAMA oncology 4 (11), 1616-1617, 2018 | 17 | 2018 |
| Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors B Zhou, B Kwan, MJ Desai, V Nalawade, KJ Ruddy, PC Nathan, HJ Henk, ... Fertility and sterility 117 (5), 1047-1056, 2022 | 15 | 2022 |
| Metastasis and mortality in men with low-and intermediate-risk prostate cancer on active surveillance PT Courtney, R Deka, NV Kotha, DR Cherry, MA Salans, TJ Nelson, ... Journal of the National Comprehensive Cancer Network 20 (2), 151-159, 2022 | 15 | 2022 |
| Association of prostate-specific antigen velocity with clinical progression among African American and non-Hispanic white men treated for low-risk prostate cancer with active … TJ Nelson, J Javier-DesLoges, R Deka, PT Courtney, V Nalawade, L Mell, ... JAMA Network Open 4 (5), e219452-e219452, 2021 | 12 | 2021 |
| Associations among statins, preventive care, and prostate cancer mortality A Kumar, P Riviere, E Luterstein, V Nalawade, L Vitzthum, RR Sarkar, ... Prostate Cancer and Prostatic Diseases 23 (3), 475-485, 2020 | 11 | 2020 |
| Impact of underlying malignancy on emergency department utilization and outcomes AS Qian, EM Qiao, V Nalawade, RS Voora, NV Kotha, C Dameff, ... Cancer Medicine 10 (24), 9129-9138, 2021 | 9 | 2021 |
James D MurphyUniversity of California San DiegoVerified email at ucsd.edu
